Navigation Links
Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.
Date:11/5/2009

econstruction, breast enlargement, facial treatments or buttocks lift with notably higher success rates than conventional lipotransfer cosmetic procedures.

Invented in Japan by plastic surgeon Dr. Kotaro Yoshimura, the CAL soft tissue augmentation technique creates more natural and safer results compared to conventional plastic surgery techniques for breast enhancement -- of which 99% use synthetic implants. The technique involves suctioning excess fat from the patient's stomach or thighs, processing this fat and soft-tissue to enrich the adipose-derived stem cell concentration and then injecting this mix into the breast. The injected mixture, which now contains a high level of stem cells, is transplanted layer by layer into each breast to ensure an even distribution of the adipose mixture. The high concentration of stem cells in the newly injected fat supports healthy tissue growth and an increased blood supply. Over 300 women have undergone the CAL procedure since 2006 for breast reconstruction after breast cancer, replacement of breast implants or breast augmentation.

About Biomaster Inc.

Biomaster Inc. ( http://www.biomaster.jp ) is one of Japan's leading biotechnology companies, and is at the forefront of advanced research and commercialization of adipose-based stem cell therapies, focusing on regenerative medicine, tissue reconstruction and tissue engineering.

Biomaster has a blue-chip pedigree and was founded by far-sighted intellectual leaders in the Japanese venture capital community as well as leading scientists and doctors from Tokyo University, Japan's most prestigious academic institution. The company was formed in 2002, by Trans-Science, a leading venture capital company with a proven track record in the biotech field.

For more information about Biomaster's technologies or individual treatment options please contact: '/>"/>

SOURCE Shenzhen Beike Biotechnology Co. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
2. MichBio Announces Formation of Biotechnology Legislative Caucus
3. Not just humans benefit from animal biotechnology
4. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
5. Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Councils Ninth Annual MASS Opportunities Investment Conference
6. Biotechnology Builds a New Heart
7. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
10. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Newark, NJ (PRWEB) July 24, 2014 ... which will give one lucky family a rent-free week ... only until August 3, 2014. Don’t miss your chance ... The sweepstakes is open to all New Jersey residents, ... Horizon BCBSNJ Facebook page, http://www.facebook.com/HorizonBCBSNJ . , ...
(Date:7/24/2014)... with high-throughput data generated by breast cancer biologists ... computational method to determine how gene networks are ... as they respond to potential cancer therapy agents., ... each other in laboratory-grown cells is described in ... PLOS Computational Biology . , The method ...
(Date:7/24/2014)... Human Papillomavirus Vaccination (HPV) even after becoming sexually ... results than those who were never vaccinated. These ... Diseases . , Researchers from Boston University ... conducted a cross-sectional study of 235 women age ... HPV status and demographic and behavioral characteristics were ...
(Date:7/24/2014)... Los Angeles, CA (PRWEB) July 24, 2014 ... (FDA), American Optometric Association (AOA) and the Entertainment ... artists from the TV series American Horror Story ... to bring the dramatic realities of illegal ... public service campaign, which has already reached tens-of-thousands, ...
(Date:7/24/2014)... 4th Annual National Venous Interventional Summit is available ... an established Venous Endovascular Interventional Strategies group comprised ... is to provide a "How To" meeting for ... in advancing their knowledge and skills in venous ... own comprehensive venous interventional program. Topics at this ...
Breaking Medicine News(10 mins):Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 2Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 3Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 4Health News:Preliminary agenda available for 4th VEINS Conference to be held October 9-12 in Chicago 2
... announced today that,the physicians of Great Lakes Radiologists, one of ... Aurora Medical Group. , ... and,clinics. , "These are ... care we provide for Aurora patients," said Jeff Bailet, M.D., ...
... and Management Realigned to Provide Full Support for Clinical ... Md., Dec. 15 EntreMed, Inc. (Nasdaq: ... to focus the Company,s resources on its most promising ... part of the Company,s overall plan to lower operating ...
... 15, 2008 Researchers from Yale University School ... magnification to standard white light colonoscopy in differentiating ... NBI was not more accurate than white light ... curve for these experienced endoscopists using NBI as ...
... brakes on killer disease, scientists say , , MONDAY, Dec. ... gene may provide a new target for treating deadly ... Mayo Clinic College of Medicine in Minnesota show the ... in another gene that, in a mutated form, has ...
... Imaging(R),Inc., a wholly owned subsidiary of Mercury Computer ... it has received FDA 510(k) clearance to market,its ... This release brings,significant enhancements to its prior offerings ... Neuroradiology and Oncology applications. The Neuro,option facilitates brain ...
... 15 Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: ... in the Clinical and Sports Nutrition Market, announces financial results ... , Net revenue for the third ... in the third quarter 2007. The Company reduced its, ...
Cached Medicine News:Health News:Great Lakes Radiologists to Join Aurora Medical Group 2Health News:EntreMed Focuses on Development of ENMD-2076 2Health News:EntreMed Focuses on Development of ENMD-2076 3Health News:EntreMed Focuses on Development of ENMD-2076 4Health News:EntreMed Focuses on Development of ENMD-2076 5Health News:Narrow-band imaging comparable to white light colonoscopy in differentiating colorectal polyps 2Health News:Narrow-band imaging comparable to white light colonoscopy in differentiating colorectal polyps 3Health News:Narrow-band imaging comparable to white light colonoscopy in differentiating colorectal polyps 4Health News:Pancreatic Cancer May Have a New Foe 2Health News:Visage Imaging Receives FDA 510(k) Clearance for its Latest Thin Client Product Release 2Health News:Visage Imaging Receives FDA 510(k) Clearance for its Latest Thin Client Product Release 3Health News:Visage Imaging Receives FDA 510(k) Clearance for its Latest Thin Client Product Release 4Health News:Millennium Biotechnologies Reports Strong Third Quarter Revenue and Financial Results 2Health News:Millennium Biotechnologies Reports Strong Third Quarter Revenue and Financial Results 3
(Date:7/24/2014)... July 24, 2014 Consolidated Net Profit increased ... Highlights   , India Business grew by 20.87% ... to Rs. 4,886.70 Mn Rest of World (ROW) Business ... Business grew by 34.53% to Rs. 977.26 Mn Latin ... Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical ...
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- Delivery ... once order is placed. Photo - ... a professional and in-depth market survey on Global ... reviews the basic information of Hemodialysis Machine including ... then explores global and China,s top manufacturers of ...
(Date:7/24/2014)... Scotland , July 24, 2014 Cancer patients ... gain access to state-of-the-art cancer treatment closer to home when ... next year. Varian Medical Systems (NYSE: VAR ... an order was placed in June for four TrueBeam™ medical ... systems, which offer fast and efficient radiotherapy and radiosurgery treatments, ...
Breaking Medicine Technology:Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3
... Incorporated (Nasdaq: ARAY ), the premier radiation oncology ... Euan S. Thomson, Ph.D., is scheduled to present at the ... City on Tuesday November 15, 2011 at 10:30 a.m. EST/7:30 ... the Stephens Fall Investment Conference in New York City on ...
... PARSIPPANY, N.J., Nov. 10, 2011 Columbia Laboratories, Inc. ... (NYSE: WPI ), today confirmed that the ... Food and Drug Administration (FDA) is scheduled to review ... for the reduction of risk of preterm birth in ...
Cached Medicine Technology:Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 2Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 3Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 4
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... glucose monitor elevates bedside glucose testing to ... approaches the quality of central laboratory testing. ... measuring strip technology. Current glucose strips ... Multi-Well system measures and corrects hematocrit interference ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... The BreatheX is a wearable CPAP ... treatment of sleep apnea. The lightweight BreatheX ... of therapy with its built-in, rechargeable battery, ... users will no longer need to be ...
Medicine Products: